Explore more publications!

Wellness Daily Nauru: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Daily Nauru.

November 2025

December 2025

January 2026

Press releases published on January 15, 2026

Digbi Health Publishes Peer-Reviewed Data Demonstrating Significant Cost Savings for Employers Via Its Precision Biology Telehealth Platform to Manage GLP-1, Metabolic, and GI Costs

January 15, 2026

Digbi Health Publishes Peer-Reviewed Data Demonstrating Significant Cost Savings for Employers Via Its Precision Biology Telehealth Platform to Manage GLP-1, Metabolic, and GI Costs

GlobeNewswire

Verdane Invests in Clue to Accelerate the Future of Women’s Health

January 15, 2026

Verdane Invests in Clue to Accelerate the Future of Women’s Health

GlobeNewswire

Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market

January 15, 2026

Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market

GlobeNewswire

Press Release: Myqorzo and Redemplo approved in China

January 15, 2026

Press Release: Myqorzo and Redemplo approved in China

GlobeNewswire

Communiqué de presse : Myqorzo et Redemplo approuvés en Chine

January 15, 2026

Communiqué de presse : Myqorzo et Redemplo approuvés en Chine

GlobeNewswire

Santhera erhält Swissmedic-Zulassung für AGAMREE® (Vamorolon) zur Behandlung von Duchenne-Muskeldystrophie

January 15, 2026

Santhera erhält Swissmedic-Zulassung für AGAMREE® (Vamorolon) zur Behandlung von Duchenne-Muskeldystrophie

GlobeNewswire

Santhera Receives Swissmedic Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy

January 15, 2026

Santhera Receives Swissmedic Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire

Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference

January 15, 2026

Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

January 15, 2026

Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

GlobeNewswire